Detalhe da pesquisa
1.
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
Future Oncol
; 19(23): 1577-1591, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334673
2.
Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.
Cancer
; 123(16): 3080-3087, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440955
3.
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
Gynecol Oncol
; 147(2): 402-407, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843653
4.
Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
Cancer Metastasis Rev
; 34(1): 5-10, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25597035
5.
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Gynecol Oncol
; 143(2): 294-301, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542967
6.
Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.
Appl Immunohistochem Mol Morphol
; 30(1): 27-35, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224438
7.
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.
J Clin Oncol
; 38(16): 1824-1835, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213105
8.
Metastatic squamous cell carcinoma of the vulva to the lung confirmed with allelotyping.
Int J Gynecol Pathol
; 28(5): 497-501, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19696623
9.
Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer.
Hematol Oncol Clin North Am
; 32(6): 1057-1071, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390760
10.
EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma.
Surgery
; 154(4): 739-46; discussion 746-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24074410